Lenacapavir Production in South Africa Moves Closer

Original Article by Tamar Kahn | Business Day | 31 July 2026

Lenacapavir production moves closer in SA as three local pharmaceutical manufacturers are shortlisted to produce the HIV-prevention injection.

Image | Sukhina Marina | Adobe Stock/1611459282

Lenacapavir production moves closer in SA as three local pharmaceutical manufacturers are shortlisted to produce the HIV-prevention injection.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.

Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.

GLP-1 medicines alone can’t solve SA’s diabetes crisis, experts warn, urging earlier screening, coordinated care and better food access.